A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors
Clinical trial NCT05491317 · TERMINATED
Trial details
- NCT number
- NCT05491317
- Sponsor
- Genmab
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-08
- Primary completion
- 2025-08-11
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.